AD development is thought to be influenced by primary pathogenic pathways: amyloid-beta (Aβ) peptide deposition, tau hyperphosphorylation with forming tau neurofibrillary tangles, cholinergic deficit, oxidative stress, and chronic neuroinflammation [1,2]. The gene discussed is MAPT; the disease is Alzheimer disease.